Merck halts development of two COVID-19 vaccine candidates after inadequate response
The company will continue to research two investigational therapeutic candidates
Pfizer launches COVID-19 vaccine trial in pregnant women
Pfizer and BioNTech will jab approximately 4000 pregnant women with their experimental COVID-19 vaccines in an effort to understand the vaccine’s effects. Globally, millions have already received shots of the vaccines authorized for emergency use.
Oxford study finds asthma treatment Budesonide reduced COVID-19 symptoms, sped up recovery
It reduced the likelihood of requiring urgent care, emergency department consultation or hospitalization.
Pfizer withdraws application for authorization of COVID-19 vaccine in India
The decision followed the Indian drug regulator’s request for ‘bridging trials’
[WATCH] Is the Pfizer and BioNTech Vaccine Safe and Effective? INN THE WIKI | Part 1/2
Vera and Natalia talk about research related to our future and Covid-19 vaccinations in this two part episode. What are the effects of the Pfizer vaccine? Is there foul play in the banning and suspected death of some prominent journalists questioning the safety of the vaccines? READ THE ARTICLE HERE: WHERE ELSE TO WATCH PART […]
Matt Hancock slammed for proposal to pay £500 to everyone who tests positive for COVID-19
“Just Bonkers,” one official said, “The whole country will suddenly develop a dry cough.”
Moderna adds three new mRNA-based vaccines to research pipeline
The biotech company announced it is developing vaccines against influenza, HIV, and the Nipah virus
Ontario has no protocols to ensure reliability of COVID-19 PCR tests
Hospitals and laboratories across the province are using astronomically high Ct levels for PCR tests, making the results less reliable
Florida prioritizes vaccine to permanent, seasonal residents
To quell “vaccine tourism,” out-of-state residents, foreigners are no longer eligible for vaccines
Laser surgery to remove brain cancer without damaging healthy tissue
UK scientists will be developing the laser system for the next three years
